Genomic Health 2019 annual meeting is June 13th. To enhance long-term value. Vote WITTHOLD all directors except Popovits & Parker; AGAINST Stock Plan, Pay, Auditor. Vote FOR Simple Majority Vote. (more…)
Tag Archives | Felix J. Baker
Genomic Health: Proxy Score 60
Genomic Health, Inc. (NASD:GHDX), one of the stocks in my portfolio, is a molecular diagnostics company focused on the global development and commercialization of genomic-based clinical laboratory services that analyze the underlying biology of cancer allowing physicians and patients to make individualized treatment decisions. Their annual meeting is coming up on 6/11/2015. ProxyDemocracy.org had the vote of one […]